Compare EDU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDU | BIO |
|---|---|---|
| Founded | 1993 | 1952 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 10.1B |
| IPO Year | 2006 | 1994 |
| Metric | EDU | BIO |
|---|---|---|
| Price | $58.42 | $367.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 3 |
| Target Price | $73.62 | ★ $335.00 |
| AVG Volume (30 Days) | ★ 514.3K | 221.8K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | $16.58 | N/A |
| Revenue Next Year | $12.33 | $2.13 |
| P/E Ratio | $24.75 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $44.25 | $236.73 |
| 52 Week High | $64.97 | $396.23 |
| Indicator | EDU | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | 52.06 |
| Support Level | $53.79 | $358.85 |
| Resistance Level | $59.39 | $391.87 |
| Average True Range (ATR) | 1.49 | 12.10 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 43.55 | 49.59 |
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in livestreaming e-commerce.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.